LT2527371T - Method for the treatment of glomerulonephritis - Google Patents
Method for the treatment of glomerulonephritisInfo
- Publication number
- LT2527371T LT2527371T LTEP12174216.7T LT12174216T LT2527371T LT 2527371 T LT2527371 T LT 2527371T LT 12174216 T LT12174216 T LT 12174216T LT 2527371 T LT2527371 T LT 2527371T
- Authority
- LT
- Lithuania
- Prior art keywords
- glomerulonephritis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Photolithography (AREA)
- Photoreceptors In Electrophotography (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0717337.0A GB0717337D0 (en) | 2007-09-06 | 2007-09-06 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2527371T true LT2527371T (en) | 2016-10-25 |
Family
ID=38640341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP12174216.7T LT2527371T (en) | 2007-09-06 | 2008-09-04 | Method for the treatment of glomerulonephritis |
Country Status (14)
Country | Link |
---|---|
US (1) | US9321837B2 (en) |
EP (2) | EP2527371B1 (en) |
CY (1) | CY1118333T1 (en) |
DK (1) | DK2527371T3 (en) |
ES (2) | ES2595388T3 (en) |
GB (1) | GB0717337D0 (en) |
HR (1) | HRP20161460T1 (en) |
HU (1) | HUE031032T2 (en) |
LT (1) | LT2527371T (en) |
PL (1) | PL2527371T3 (en) |
PT (1) | PT2527371T (en) |
RS (1) | RS55281B1 (en) |
SI (1) | SI2527371T1 (en) |
WO (1) | WO2009030936A1 (en) |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
GB8720833D0 (en) | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
US5670373A (en) * | 1988-01-22 | 1997-09-23 | Kishimoto; Tadamitsu | Antibody to human interleukin-6 receptor |
EP1997891A1 (en) | 1988-09-02 | 2008-12-03 | Dyax Corporation | Generation and selection of recombinant varied binding proteins |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
WO1991010737A1 (en) | 1990-01-11 | 1991-07-25 | Molecular Affinities Corporation | Production of antibodies using gene libraries |
US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
CA2090126C (en) | 1990-08-02 | 2002-10-22 | John W. Schrader | Methods for the production of proteins with a desired function |
US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
CA2405246A1 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with alterred binding properties |
DK1471142T3 (en) | 1991-04-10 | 2009-03-09 | Scripps Research Inst | Heterodimeric receptor libraries using phagemids |
DE69233782D1 (en) | 1991-12-02 | 2010-05-20 | Medical Res Council | Preparation of Autoantibodies on Phage Surfaces Starting from Antibody Segment Libraries |
US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
WO1994028159A1 (en) | 1993-05-31 | 1994-12-08 | Chugai Seiyaku Kabushiki Kaisha | Reconstructed human antibody against human interleukin-6 |
EP0733070A1 (en) | 1993-12-08 | 1996-09-25 | Genzyme Corporation | Process for generating specific antibodies |
WO1995020401A1 (en) | 1994-01-31 | 1995-08-03 | Trustees Of Boston University | Polyclonal antibody libraries |
FR2716640B1 (en) | 1994-02-28 | 1996-05-03 | Procedes Machines Speciales | Device for centering and blocking a workpiece with a view to running it in using an expansion lapper. |
US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
JP2978435B2 (en) | 1996-01-24 | 1999-11-15 | チッソ株式会社 | Method for producing acryloxypropyl silane |
GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
DE69839517D1 (en) | 1997-08-15 | 2008-07-03 | Chugai Pharmaceutical Co Ltd | PREVENTIVA OR ARZNEIA CONTAINING NEUTRALIZING ANTI-IL6 RECEPTOR ANTIBODIES FOR REDUCING URINARY PROTEINS IN SYSTEMIC LUPUS ERYTHEMATOSUS |
GB9720054D0 (en) | 1997-09-19 | 1997-11-19 | Celltech Therapeutics Ltd | Biological products |
AU2002346369B2 (en) | 2001-11-14 | 2009-08-27 | Eusa Pharma (Uk) Ltd | Anti-IL-6 antibodies, compositions, methods and uses |
EP1570267B1 (en) | 2002-12-03 | 2011-10-12 | UCB Pharma, S.A. | Assay for identifying antibody producing cells |
GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
GB0312481D0 (en) | 2003-05-30 | 2003-07-09 | Celltech R&D Ltd | Antibodies |
GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
WO2005003169A2 (en) | 2003-07-01 | 2005-01-13 | Celltech R & D Limited | Modified antibody fab fragments |
GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
GB0412181D0 (en) | 2004-06-01 | 2004-06-30 | Celltech R&D Ltd | Biological products |
ES2932398T3 (en) | 2010-05-28 | 2023-01-18 | Chugai Pharmaceutical Co Ltd | Antitumor T cell response enhancer |
-
2007
- 2007-09-06 GB GBGB0717337.0A patent/GB0717337D0/en not_active Ceased
-
2008
- 2008-09-04 PL PL12174216T patent/PL2527371T3/en unknown
- 2008-09-04 SI SI200831682A patent/SI2527371T1/en unknown
- 2008-09-04 WO PCT/GB2008/003046 patent/WO2009030936A1/en active Application Filing
- 2008-09-04 HU HUE12174216A patent/HUE031032T2/en unknown
- 2008-09-04 US US12/676,297 patent/US9321837B2/en active Active
- 2008-09-04 RS RS20160884A patent/RS55281B1/en unknown
- 2008-09-04 ES ES12174216.7T patent/ES2595388T3/en active Active
- 2008-09-04 ES ES08806216T patent/ES2429445T3/en active Active
- 2008-09-04 LT LTEP12174216.7T patent/LT2527371T/en unknown
- 2008-09-04 PT PT121742167T patent/PT2527371T/en unknown
- 2008-09-04 EP EP12174216.7A patent/EP2527371B1/en not_active Revoked
- 2008-09-04 EP EP08806216.1A patent/EP2197915B1/en active Active
- 2008-09-04 DK DK12174216.7T patent/DK2527371T3/en active
-
2016
- 2016-11-03 HR HRP20161460TT patent/HRP20161460T1/en unknown
- 2016-11-17 CY CY20161101185T patent/CY1118333T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2527371B1 (en) | 2016-08-17 |
WO2009030936A1 (en) | 2009-03-12 |
RS55281B1 (en) | 2017-03-31 |
EP2197915A1 (en) | 2010-06-23 |
PT2527371T (en) | 2016-11-23 |
EP2527371A1 (en) | 2012-11-28 |
US9321837B2 (en) | 2016-04-26 |
US20100310564A1 (en) | 2010-12-09 |
SI2527371T1 (en) | 2016-11-30 |
PL2527371T3 (en) | 2017-02-28 |
CY1118333T1 (en) | 2017-06-28 |
HUE031032T2 (en) | 2017-06-28 |
GB0717337D0 (en) | 2007-10-17 |
ES2429445T3 (en) | 2013-11-14 |
DK2527371T3 (en) | 2016-10-24 |
ES2595388T3 (en) | 2016-12-29 |
HRP20161460T1 (en) | 2016-12-16 |
EP2197915B1 (en) | 2013-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1208237A1 (en) | Methods for the treatment of gout | |
PL2303021T3 (en) | Compounds for the treatment of cancer | |
IL212348A0 (en) | Treatment method | |
AU2008272903A8 (en) | Treatment for anxiety | |
GB0714363D0 (en) | Treatment apparatus | |
EP2352515A4 (en) | Method for the treatment of hemophilia | |
EP2032131A4 (en) | Method of treatment | |
GB0610746D0 (en) | Method of treatment | |
EP2341936A4 (en) | METHODS FOR TREATING OR PREVENTING IL-1ß RELATED DISEASES | |
HK1203305A1 (en) | Methods for treating psoriasis | |
EP2350641A4 (en) | Method of treatment | |
ZA201003425B (en) | 5-cyano-thienopyridines for the treatment of tumors | |
GB2449996B (en) | Effluent treatment process | |
IL193669A0 (en) | Apparatus for the treatment of bruxism | |
IL210066A0 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
GB0718684D0 (en) | Treatment method | |
IL243809A0 (en) | Process for the procuction of γ-ketosulfide compounds and γ-ketosulfide compounds | |
EP2182884A4 (en) | Treatment apparatus | |
EP2164494A4 (en) | Methods of treatment | |
GB0723100D0 (en) | Treatment of HFnEF | |
PL2326551T3 (en) | Apparatus for the treatment of wastewater | |
EP2209488A4 (en) | Fgf9-related methods for treating anxiety | |
IL213287A0 (en) | Treatment for glomerulonephritis | |
PL2527371T3 (en) | Method for the treatment of glomerulonephritis | |
EP2203432A4 (en) | Method of treatment |